Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, L., MiRNA-based Life-span extension therapy: Tumor suppressor p53 homologue p63 increases life span by suppressing mTOR pathway through up regulation of miR-130, 27/January/2014, 22.43, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at firstname.lastname@example.org
* Research cooperation
Significance: This study suggests, for the first time, that p63, by increasing the expression of its target gene miRNA-130, it may suppress the expression of mTOR. Thereby, it may increase the lifespan of an individual, as it has been shown earlier that decreasing the expression of mTOR increases overall lifespan. Together, this study suggests that pharmacological formulations encompassing “p63 or its activators or miRNA-130 or its activators” may function as longevity promoters.